Annual EBIT
-$3.97 M
+$22.50 M+84.99%
31 December 2023
Summary:
Sunshine Biopharma annual earnings before interest & taxes is currently -$3.97 million, with the most recent change of +$22.50 million (+84.99%) on 31 December 2023. During the last 3 years, it has fallen by -$1.36 million (-51.90%). SBFMW annual EBIT is now -30181.74% below its all-time high of -$13.12 thousand, reached on 31 July 2007.SBFMW EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$982.59 K
-$144.84 K-17.29%
30 September 2024
Summary:
Sunshine Biopharma quarterly earnings before interest & taxes is currently -$982.59 thousand, with the most recent change of -$144.84 thousand (-17.29%) on 30 September 2024. Over the past year, it has dropped by -$410.58 thousand (-71.78%). SBFMW quarterly EBIT is now -164.97% below its all-time high of $1.51 million, reached on 30 September 2010.SBFMW Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$4.03 M
-$410.58 K-11.34%
30 September 2024
Summary:
Sunshine Biopharma TTM earnings before interest & taxes is currently -$4.03 million, with the most recent change of -$410.58 thousand (-11.34%) on 30 September 2024. Over the past year, it has increased by +$22.19 million (+84.63%). SBFMW TTM EBIT is now -476.98% below its all-time high of $1.07 million, reached on 30 June 2011.SBFMW TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SBFMW EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +85.0% | -71.8% | +84.6% |
| 3 y3 years | -51.9% | +75.4% | +70.8% |
| 5 y5 years | -99.0% | -204.8% | -173.4% |
SBFMW EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -51.9% | +85.0% | -239.6% | +95.8% | -60.3% | +85.1% |
| 5 y | 5 years | -157.3% | +85.0% | -239.6% | +95.8% | -189.8% | +85.1% |
| alltime | all time | <-9999.0% | +85.0% | -165.0% | +95.8% | -477.0% | +85.1% |
Sunshine Biopharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$982.59 K(+17.3%) | -$4.03 M(+11.3%) |
| June 2024 | - | -$837.75 K(-30.9%) | -$3.62 M(+1.4%) |
| Mar 2024 | - | -$1.21 M(+21.3%) | -$3.57 M(-10.1%) |
| Dec 2023 | -$3.97 M(-85.0%) | -$999.65 K(+74.8%) | -$3.97 M(-84.8%) |
| Sept 2023 | - | -$572.00 K(-27.3%) | -$26.23 M(-3.3%) |
| June 2023 | - | -$786.84 K(-51.3%) | -$27.11 M(+0.9%) |
| Mar 2023 | - | -$1.62 M(-93.1%) | -$26.86 M(+1.5%) |
| Dec 2022 | -$26.47 M(+118.6%) | -$23.25 M(+1495.9%) | -$26.47 M(+952.3%) |
| Sept 2022 | - | -$1.46 M(+170.4%) | -$2.52 M(-50.2%) |
| June 2022 | - | -$538.87 K(-56.0%) | -$5.05 M(-29.8%) |
| Mar 2022 | - | -$1.22 M(-273.8%) | -$7.20 M(-40.6%) |
| Dec 2021 | -$12.11 M(+362.8%) | $703.75 K(-117.6%) | -$12.11 M(-12.2%) |
| Sept 2021 | - | -$3.99 M(+48.8%) | -$13.79 M(+31.7%) |
| June 2021 | - | -$2.68 M(-56.3%) | -$10.47 M(+24.6%) |
| Mar 2021 | - | -$6.14 M(+527.1%) | -$8.41 M(+257.7%) |
| Dec 2020 | -$2.62 M(+69.4%) | -$978.36 K(+44.6%) | -$2.35 M(+34.7%) |
| Sept 2020 | - | -$676.50 K(+9.5%) | -$1.75 M(+25.4%) |
| June 2020 | - | -$617.95 K(+693.2%) | -$1.39 M(-5.1%) |
| Mar 2020 | - | -$77.90 K(-79.1%) | -$1.47 M(-4.9%) |
| Dec 2019 | -$1.54 M(-22.7%) | -$373.20 K(+15.8%) | -$1.54 M(+4.5%) |
| Sept 2019 | - | -$322.39 K(-53.4%) | -$1.48 M(-27.5%) |
| June 2019 | - | -$692.55 K(+353.5%) | -$2.04 M(+3.9%) |
| Mar 2019 | - | -$152.73 K(-50.3%) | -$1.96 M(-1.9%) |
| Dec 2018 | -$2.00 M(+113.5%) | -$307.42 K(-65.2%) | -$2.00 M(+8.4%) |
| Sept 2018 | - | -$883.22 K(+43.4%) | -$1.84 M(+70.7%) |
| June 2018 | - | -$615.93 K(+223.9%) | -$1.08 M(+14.9%) |
| Mar 2018 | - | -$190.17 K(+24.4%) | -$939.02 K(+0.4%) |
| Dec 2017 | -$935.41 K(-73.0%) | -$152.82 K(+27.2%) | -$935.41 K(-50.8%) |
| Sept 2017 | - | -$120.18 K(-74.7%) | -$1.90 M(-43.3%) |
| June 2017 | - | -$475.85 K(+155.1%) | -$3.35 M(+0.1%) |
| Mar 2017 | - | -$186.56 K(-83.3%) | -$3.35 M(-3.2%) |
| Dec 2016 | -$3.46 M | -$1.12 M(-28.9%) | -$3.46 M(+26.7%) |
| Sept 2016 | - | -$1.57 M(+233.9%) | -$2.73 M(+102.1%) |
| June 2016 | - | -$471.31 K(+58.0%) | -$1.35 M(-1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | -$298.34 K(-23.4%) | -$1.37 M(+14.6%) |
| Dec 2015 | -$1.35 M(-23.3%) | -$389.65 K(+101.8%) | -$1.19 M(+7.5%) |
| Sept 2015 | - | -$193.06 K(-60.1%) | -$1.11 M(-7.1%) |
| June 2015 | - | -$484.29 K(+288.0%) | -$1.19 M(-19.1%) |
| Mar 2015 | - | -$124.83 K(-59.2%) | -$1.47 M(-16.0%) |
| Dec 2014 | -$1.76 M(-29.4%) | -$306.30 K(+10.4%) | -$1.76 M(-17.8%) |
| Sept 2014 | - | -$277.43 K(-63.8%) | -$2.13 M(+4.9%) |
| June 2014 | - | -$765.51 K(+88.6%) | -$2.03 M(+43.1%) |
| Mar 2014 | - | -$405.87 K(-40.8%) | -$1.42 M(-42.9%) |
| Dec 2013 | -$2.49 M(+251.6%) | -$685.41 K(+285.7%) | -$2.49 M(+25.0%) |
| Sept 2013 | - | -$177.68 K(+16.4%) | -$1.99 M(-9.1%) |
| June 2013 | - | -$152.59 K(-89.6%) | -$2.19 M(+2.3%) |
| Mar 2013 | - | -$1.47 M(+681.8%) | -$2.14 M(+202.7%) |
| Dec 2012 | -$706.68 K(+27.1%) | -$188.26 K(-50.0%) | -$706.68 K(-20.6%) |
| Sept 2012 | - | -$376.41 K(+266.5%) | -$890.48 K(+41.2%) |
| June 2012 | - | -$102.69 K(+161.1%) | -$630.51 K(+15.8%) |
| Mar 2012 | - | -$39.33 K(-89.4%) | -$544.31 K(-1.8%) |
| Dec 2011 | -$556.20 K(+3.5%) | -$372.06 K(+219.5%) | -$554.20 K(-0.9%) |
| Sept 2011 | - | -$116.44 K(+606.1%) | -$559.09 K(-152.3%) |
| June 2011 | - | -$16.49 K(-66.5%) | $1.07 M(-313.1%) |
| Mar 2011 | - | -$49.22 K(-86.9%) | -$501.95 K(-6.6%) |
| Dec 2010 | -$537.38 K(+1960.6%) | -$376.95 K(-124.9%) | -$537.38 K(+235.0%) |
| Sept 2010 | - | $1.51 M(-195.2%) | -$160.44 K(-94.3%) |
| June 2010 | - | -$1.59 M(+1776.1%) | -$2.81 M(+129.4%) |
| Mar 2010 | - | -$84.65 K(-92.5%) | -$1.22 M(+6.9%) |
| Oct 2009 | - | -$1.13 M(>+9900.0%) | -$1.14 M(+7209.9%) |
| July 2009 | - | -$5191.00(+110.2%) | -$15.65 K(+6.4%) |
| Apr 2009 | - | -$2470.00(-26.3%) | -$14.70 K(-36.1%) |
| Jan 2009 | - | -$3353.00(-27.7%) | -$23.02 K(+5.0%) |
| Oct 2008 | - | -$4638.00(+9.3%) | -$21.93 K(-15.9%) |
| July 2008 | -$26.08 K(+98.7%) | -$4243.00(-60.6%) | -$26.08 K(+19.4%) |
| Apr 2008 | - | -$10.78 K(+376.0%) | -$21.84 K(+97.5%) |
| Jan 2008 | - | -$2265.00(-74.2%) | -$11.05 K(+25.8%) |
| Oct 2007 | - | -$8788.00 | -$8788.00 |
| July 2007 | -$13.12 K | - | - |
FAQ
- What is Sunshine Biopharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Sunshine Biopharma?
- What is Sunshine Biopharma annual EBIT year-on-year change?
- What is Sunshine Biopharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly EBIT year-on-year change?
- What is Sunshine Biopharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Sunshine Biopharma?
- What is Sunshine Biopharma TTM EBIT year-on-year change?
What is Sunshine Biopharma annual earnings before interest & taxes?
The current annual EBIT of SBFMW is -$3.97 M
What is the all time high annual EBIT for Sunshine Biopharma?
Sunshine Biopharma all-time high annual earnings before interest & taxes is -$13.12 K
What is Sunshine Biopharma annual EBIT year-on-year change?
Over the past year, SBFMW annual earnings before interest & taxes has changed by +$22.50 M (+84.99%)
What is Sunshine Biopharma quarterly earnings before interest & taxes?
The current quarterly EBIT of SBFMW is -$982.59 K
What is the all time high quarterly EBIT for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly earnings before interest & taxes is $1.51 M
What is Sunshine Biopharma quarterly EBIT year-on-year change?
Over the past year, SBFMW quarterly earnings before interest & taxes has changed by -$410.58 K (-71.78%)
What is Sunshine Biopharma TTM earnings before interest & taxes?
The current TTM EBIT of SBFMW is -$4.03 M
What is the all time high TTM EBIT for Sunshine Biopharma?
Sunshine Biopharma all-time high TTM earnings before interest & taxes is $1.07 M
What is Sunshine Biopharma TTM EBIT year-on-year change?
Over the past year, SBFMW TTM earnings before interest & taxes has changed by +$22.19 M (+84.63%)